FDA’s current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic communications environment.
Innovation is still valued in the orphan-drug space, but the reimbursement bar is rising. NPS Pharma’s Eric Pauwels, who’s launched five ultra-rare disease products, explains how these biotech brands can demonstrate their value. Marc Iskowitz reports
A major information explosion is just the tip of the iceberg in the paradigm shift that is taking place between pharma, marketers and the patients that they serve. James Chase asks experts from across the patient-to-pharma spectrum how the industry can negotiate the new environment to successfully put patients first
When assessing the value of breakthrough drugs, Health Economics & Outcomes Research can help generate the economic profile of a new therapy. Mohan Bala and Meghan Gallagher explain its use
Immunotherapy is an emerging powerhouse in cancer treatment. Early gains being made in multiple tumor types provide a glimpse of the effectiveness of several agents and regimens. While longer follow-up is needed, the results have analysts talking about a big shift in the war on cancer. Joe Dysart reports
Pharma is moving toward a broader treatment paradigm based on providing additional services for patients. Boris Kushkuley describes what the Pill+ model looks like, and how multichannel marketing can facilitate it
More than 100 esteemed industry leaders and thinkers spent several hours discussing, reviewing and scoring around 700 entries to the MM&M Awards. Here are the results of their efforts—the 2014 finalists
Pharma cites “payer pressure” as one of its biggest marketing challenges yet struggles to make the “value” case for products. How can it translate market-access awareness into reimbursement success?
Read the complete August 2014 Digital Edition
August 1, 2014
4:00 am
Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.